Therefore, a novel approach that enhances the CXCR7/ERK signaling pathways can also potentially enhance the EPCs vasculogenic activities while reversing the vascular endothelial integrity and homeostasis in CAD patients. Here, ACKR3 is linked to coronary artery disorder.